“We’re not inventing a completely new drug, we are re-purposing the delivery device”
It’s 9:45 p.m. on a run of the mill Tuesday and Shaan Hooey is tired.
It’s been a long day for the Canadian entrepreneur who spent most of it talking to investors and answering media calls but you wouldn’t know it by how excited he is when discussing his medical startup, GlucaMed. The company has created its first prototype for an injectable pen that contains glucagon, a medication used to treat low-blood sugar in Type 1 diabetics.
From his home, Hooey describes over the phone how he and his partner, Sameer Jessa, managed to get the business off the ground in great detail. But, perhaps, the most compelling part of his story is that the co-founders behind this game-changing piece of technology are only 15 years old.
“Innovation is my motivation,” he says, with a laugh. “I was inspired to create the [Glucopen] because my sister has diabetes and I saw the pains she had to go through. I saw when she would have to sit on the sidelines [because of] low blood sugar and I thought there had to be a better way.”
Jessa agrees.“I’ve actually met with Shaan’s sister and I’ve seen how she’s struggled with her diabetes,” he says. “No diabetics should have to live with their life in danger.”
Read more at the source